Tamás Resál - Szent-Györgyi Albert Medical School- Department of Medicine, University of Szeged

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 67 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Shotgun Analysis of Gut Microbiota with Body Composition and Lipid Characteristics in Crohn’s Disease

Peter Bacsur,Tamas Resal,Bernadett Farkas,Boldizsar Jojart,Zoltan Gyuris,Gabor Jaksa,Lajos Pinter,Bertalan Takacs, Sara Pal, Attila Gacser,Kata Judit Szanto,Mariann Rutka,Renata Bor,Anna Fabian,Klaudia Farkas,Jozsef Maleth,Zoltan Szepes,Tamas Molnar,Anita Balint

BIOMEDICINESno. 9 (2024)

引用0浏览0WOS引用

Accuracy of the Pancolonic Modified Mayo Score in Predicting the Long-Term Outcomes of Ulcerative Colitis: a Promising Scoring System

Peter Bacsur,Panu Wetwittayakhlang,Tamas Resal, Emese Foldi,Bela Vasas,Bernadett Farkas,Mariann Rutka,Talat Bessissow,Waqqas Afif,Anita Balint,Anna Fabian,Renata Bor,Zoltan Szepes,Klaudia Farkas,Peter L. Lakatos,Tamas Molnar

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2024)

引用0浏览0WOS引用

Long-term Outcomes after Endoscopic Removal of Malignant Colorectal Polyps: Results from a 10-Year Cohort

Anna Fábián,Renáta Bor,Béla Vasas,Mónika Szűcs, T Tóth, Zsuzsa Bösze,K Szántó,Péter Bacsúr,Anita Bálint,Bernadett Farkas,Klaudia Farkas,Ágnes Milassin,Mariann Rutka,Tamás Resál,Tamás Molnár,Zoltán Szepes

Endoscopy (2024)

引用0浏览0引用

P674 Real-world Experiences of Switching to Subcutaneous Formulation in IBD Patients on Maintenance Vedolizumab Treatment

P. Bacsur,T. Resal,B. Farkas,P. Sarlos,A. Ilias,D. Kata,A. Balint,A. Fabian,R. Bor,Z. Szepes,T. Molnar,K. Farkas

JOURNAL OF CROHNS & COLITIS (2024): I1269-I1270

引用0浏览0引用

Plasminogen Activator Inhibitor 1 is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases

Boldizsar Jojart,Tamas Resal,Diana Kata, Tuende Molnar,Peter Bacsur,Viktoria Szabo,Arpad Varga,Kata Judit Szanto,Petra Pallagi,Imre Foldesi,Tamas Molnar,Jozsef Maleth,Klaudia Farkas

JOURNAL OF CROHNS & COLITISno. 3 (2024): 392-405

引用0浏览0WOS引用

Comparison of Risk of Malignancy and Predictive Value of Diagnostic Categories Defined by Papanicolaou Society of Cytopathology System and WHO Reporting System for Pancreaticobiliary Cytopathology in Solid Pancreatic Lesions

Bela Vasas,Anna Fabian,Zsofia Bosze,Sandor Hamar,Laszlo Kaizer,Tibor Toth,Peter Bacsur,Tamas Resal, Anita Balint,Klaudia Farkas,Tamas Molnar,Zoltan Szepes, Renata Bor

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY（2024）

引用0浏览0WOS引用

The Faecal Biomarker LDN-051 is a Novel Tool for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases

B. Jojart,T. Resal, K. Diana,T. Molnar,P. Bacsur,V. Szabo,A. Varga,K. J. Szanto,P. Pallagi,I. Foldesi,J. Maleth,K. Farkas

JOURNAL OF CROHNS & COLITIS (2024): I861-I861

引用0浏览0引用

P560 the Impact of Reactive Point-of-care Drug Level Measurement on the Medium-Term Course of Inflammatory Bowel Disease

E. Ivany,B. Farkas,T. Resal,P. Bacsur,A. Balint,K. Farkas,T. Molnar

JOURNAL OF CROHNS & COLITIS (2024): I1090-I1090

引用0浏览0引用

P356 Long-term Outcome of UC Patients in Clinical Remission with Different Level of Mucosal Activity: Real World, Retrospective, Multicontinental Study

P. Bacsur,P. Wetwittayakhlang,T. Resal,B. Farkas,M. Rutka,T. Bessissow,W. Afif,A. Balint,A. Fabian,R. Bor,Z. Szepes,K. Farkas,P. L. Lakatos,T. Molnar

JOURNAL OF CROHNS & COLITIS (2024): I751-I752

引用0浏览0引用

P1016 Real-world Data on Sequential Therapy in Moderate-to-severe UC: Unveiling Second-Line Strategies after Anti-Tnf Failure

B. Farkas, M. Borsos,T. Resal,P. Bacsur,Z. Szepes,E. V. Savarino, L. Bertin,J. K. Limdi,K. Sethi-Arora,P. Miheller, F. Vilmos,F. Castiglione, L. Bonacci,M. Lukas,N. Maharshak, G. Berman,Z. Krznaric,P. Wetwittayakhlang,P. L. Lakatos,J. B. Seidelin,M. Attauabi,G. Michalopoulos,D. G. Ribaldone,A. Kagramanova,E. Chashkova,P. Sarlos,S. Saibeni, A. B. G. Shitrit,T. Molnar,K. Farkas

JOURNAL OF CROHNS & COLITIS (2024): I1828-I1829

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn